Home
>
National Drug Code (NDC)
>
DARAPRIM
DARAPRIM - 52054-330-10 - (pyrimethamine)
Drug Information of DARAPRIM
| Product NDC: | 52054-330 |
| Proprietary Name: | DARAPRIM |
| Non Proprietary Name: | pyrimethamine |
| Active Ingredient(s): | 25 mg/1 & nbsp; pyrimethamine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DARAPRIM
| Product NDC: | 52054-330 |
| Labeler Name: | Amedra Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA008578 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19850416 |
Package Information of DARAPRIM
| Package NDC: | 52054-330-10 |
| Package Description: | 100 TABLET in 1 BOTTLE (52054-330-10) |
NDC Information of DARAPRIM
| NDC Code | 52054-330-10 |
| Proprietary Name | DARAPRIM |
| Package Description | 100 TABLET in 1 BOTTLE (52054-330-10) |
| Product NDC | 52054-330 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pyrimethamine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19850416 |
| Marketing Category Name | NDA |
| Labeler Name | Amedra Pharmaceuticals |
| Substance Name | PYRIMETHAMINE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dihydrofolate Reductase Inhibitor Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
